Abrahamsen, Cathrine, Beadsworth, Mike, Bostock, Will et al. · Scandinavian journal of primary health care · 2026 · DOI
This guideline helps doctors understand why some patients have lasting physical symptoms like fatigue, pain, and brain fog that don't show up on tests or scans. The authors explain that these symptoms often arise from how the brain responds to perceived threats, influenced by what people expect and have learned from past experiences. They recommend that doctors validate patients' symptoms, explain why they persist, and work with patients to create personalized treatment plans that address physical, psychological, and social factors together.
ME/CFS patients often face dismissal or inadequate care when symptoms lack clear biomedical explanations. This guideline legitimizes the patient experience while offering clinicians a coherent framework—grounded in neuroscience—for understanding symptom persistence and implementing compassionate, evidence-based care that may improve outcomes and reduce the frustration of repeated investigations and unhelpful consultations.
This guideline does not prove that biopsychosocial interventions will work for all ME/CFS patients, nor does it establish causation in any individual case. It is a narrative review and consensus statement, not a randomized controlled trial, so it cannot quantify treatment efficacy or identify which specific interventions are most effective. The framework proposed may not fully capture the pathophysiology of ME/CFS, which involves documented immune and metabolic abnormalities.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →